(Q34475729)

2 August 2017

1 reference

title

Gastrointestinal toxicity associated with nonsteroidal anti-inflammatory drugs. Epidemiologic and economic issues (English)

1 reference

2 August 2017

Straus WL

1

1 reference

2 August 2017

Ofman JJ

series ordinal

2

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Gastroenterology Clinics of North America

2 August 2017

published in

1 reference

2 August 2017

volume

30

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

895-920

1 reference

Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

The relation between Helicobacter pylori and nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nabumetone in elderly patients with osteoarthritis: economic benefits versus ibuprofen alone or ibuprofen plus misoprostol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

The SAGE database: introducing functional outcomes in geriatric pharmaco-epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. SAGE (Systematic Assessment of Geriatric drug use via Epidemiology) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

The conflicting relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Current status of nonsteroidal anti-inflammatory drug (NSAID) use in the United States: risk factors and frequency of complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Emergency admissions for upper gastrointestinal disease and their relation to NSAID use.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

The impact of research quality and study design on epidemiologic estimates of the effect of nonsteroidal anti-inflammatory drugs on upper gastrointestinal tract disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Gastrointestinal bleeding in older people

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Trends in the utilization of non-steroidal anti-inflammatory drugs in the United States, 1986-1990

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

The cost-effectiveness of misoprostol for nonsteroidal antiinflammatory drug-associated adverse gastrointestinal events

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Costs and effectiveness of nonsteroidal anti-inflammatory drugs: the importance of reducing side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nonsteroidal antiinflammatory drugs, ulcers and risk:A collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nonsteroidal Antiinflammatory Drugs and Gastrointestinal Hospitalizations in Saskatchewan: A Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Ecology of Helicobacter pylori in Peru: infection rates in coastal, high altitude, and jungle communities. The Gastrointestinal Physiology Working Group of the Cayetano Heredia and the Johns Hopkins University

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Management of NSAID-induced gastropathy: an economic decision analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Gastric adaptation. Studies in humans during continuous aspirin administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Economic effects of prophylactic use of misoprostol to prevent gastric ulcer in patients taking nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Analysis of the costs of NSAID-associated gastropathy. Experience in a US health maintenance organisation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

A cohort study (with re-sampled comparator groups) to measure the association between new NSAID prescribing and upper gastrointestinal hemorrhage and perforation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Association of Adrenocorticosteroid Therapy and Peptic-Ulcer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

The economic implications of cyclooxygenase-2-specific inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Silent peptic ulceration: deadly silence or golden silence?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: retrospective cohort study of an elderly population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

NSAIDs, gastrointestinal injury, and cytoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

The risks and costs of upper gastrointestinal disease attributable to NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Toxicity of Nonsteroidal Anti-Inflammatory Drugs in the Elderly: Is Advanced Age a Risk Factor?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Changing Patterns of Therapeutic Agents in the Elderly: A Ten-year Overview

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Prophylactic aspirin and risk of peptic ulcer bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970219-3

7 January 2021

10.1016/S0889-8553(05)70219-3

Identifiers

DOI

1 reference

release_rbywj4623zhhpeiegsuvwixkhi

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rbywj4623zhhpeiegsuvwixkhi

24 November 2022

mapped directly with Wikidata item

1 reference